Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy

Dec, 1994, Idiopathic dilated cardiomyopathy, N Engl J Med, 331, 1564, 10.1056/NEJM199412083312307 Eichhorn, 2001, Prognosis determination in heart failure, Am J Med, 110, 14S, 10.1016/S0002-9343(98)00384-2 Schonberger, 2001, Many roads lead to a broken heart: the genetics of dilated cardiomyopathy, Am J Hum Genet, 69, 249, 10.1086/321978 Small, 2002, Identification of adrenergic receptor polymorphisms, Methods Enzymol, 343, 459, 10.1016/S0076-6879(02)43152-7 Charron, 2002, Genes and their polymorphisms in mono- and multifactorial cardiomyopathies: towards pharmacogenomics in heart failure, Pharmacogenomics, 3, 367, 10.1517/14622416.3.3.367 Brodde, 1999, Adrenergic and muscarinic receptors in the human heart, Pharmacol Rev, 51, 651 Bristow, 1986, Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor downregulation in heart failure, Circ Res, 59, 297, 10.1161/01.RES.59.3.297 Moniotte, 2001, Upregulation of beta3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium, Circulation, 103, 1649, 10.1161/01.CIR.103.12.1649 McGraw, 1998, Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression, J Clin Invest, 102, 1927, 10.1172/JCI4862 Green, 1994, Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties, Biochemistry, 33, 9414, 10.1021/bi00198a006 Green, 1993, A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor, J Biol Chem, 268, 23116, 10.1016/S0021-9258(19)49434-9 Lefkowitz, 2000, Catecholamines, cardiac β-adrenergic receptors and heart failure, Circulation, 101, 1634, 10.1161/01.CIR.101.14.1634 Richardson, 1996, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies, Circulation, 93, 841, 10.1161/01.CIR.93.5.841 Tiret, 2000, Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study, J Am Coll Cardiol, 35, 29, 10.1016/S0735-1097(99)00522-7 Maqbool, 1999, Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay, Lancet, 353, 897, 10.1016/S0140-6736(99)00549-8 Martinez, 1997, Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing, J Clin Invest, 100, 3184, 10.1172/JCI119874 Aynacioglu, 1999, Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks, Br J Clin Pharmacol, 48, 761, 10.1046/j.1365-2125.1999.00082.x Clement, 1995, Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity, N Engl J Med, 333, 352, 10.1056/NEJM199508103330605 Colucci, 1996, Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure, Circulation, 94, 2800, 10.1161/01.CIR.94.11.2800 Terwilliger, 1994 Yancy, 2001, Clinical trials of beta-blockers in heart failure: a class review., Am J Med, 110, 7S, 10.1016/S0002-9343(01)00666-0 Bristow, 2000, Beta-adrenergic receptor blockade in chronic heart failure, Circulation, 101, 558, 10.1161/01.CIR.101.5.558 Mahon, 2002, Beta adrenergic blockers in chronic congestive cardiac failure: a call for action, Eur J Intern Med, 13, 96, 10.1016/S0953-6205(02)00010-9 Liggett, 2000, Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level, Circulation, 101, 1707, 10.1161/01.CIR.101.14.1707 Dishy, 2001, The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization, N Engl J Med, 345, 1030, 10.1056/NEJMoa010819 Drysdale, 2000, Complex promoter and coding region beta2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness, Proc Natl Acad Sci USA, 97, 10483, 10.1073/pnas.97.19.10483 Borjesson, 2000, A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure, Eur Heart J, 21, 1853, 10.1053/euhj.1999.1994 Rathz, 2002, Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking, J Cardiovasc Pharmacol, 39, 155, 10.1097/00005344-200202000-00001 Levin, 2002, The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation, J Biol Chem, 277, 30429, 10.1074/jbc.M200681200 Wagoner, 2002, Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure, Am Heart J, 144, 840, 10.1067/mhj.2002.125325 White, 2003, An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study, Eur J Heart Fail, 5, 463, 10.1016/S1388-9842(03)00044-8 Mason, 1999, A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor, J Biol Chem, 274, 12670, 10.1074/jbc.274.18.12670 Mialet Perez, 2003, Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure, Nat Med, 9, 1300, 10.1038/nm930 Small, 2002, Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure, N Engl J Med, 347, 1135, 10.1056/NEJMoa020803